Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Oral On-demand
.
Show all posts
Showing posts with label
Oral On-demand
.
Show all posts
Thursday, August 7, 2025
FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)
›
KalVista Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of Ekterly (sebetralstat), a novel plasma ka...
›
Home
View web version
